1. PH-0116: Stereotactic radiotherapy for prostate cancer: preliminary results of a phase II prospective trial. (November 2020) Authors: Nguyen, V.P.; Alzin, H.; Celine, L.; Harzée, L.; Joseph, S.; Untereiner, M.; Frédérick, B.; Biver, S.; Bodgal, Z.; Philippi, S.; Nickers, P. Journal: Radiotherapy and oncology Issue: Volume 152(2020)Supplement 1 Page Start: S58 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. PO-0841 Salvage SBRT for local prostate cancer recurrence after radiotherapy: a GETUG retrospective study. (April 2019) Authors: Martinage, G.; Janoray, G.; Rojas, D.P.; Zerini, D.; Goupy, F.; De Crevoisier, R.; Bogart, E.; Calais, G.; Toledano, A.; Chauveinc, L.; Scher, N.; Bondiau, P.Y.; Hannoun-Levi, J.M.; Silva, M.; Meyer, E.; Nickers, P.; Lacornerie, T.; Lartigau, E.; Jereczek-Fossa, B.A.; Pasquier, D. Journal: Radiotherapy and oncology Issue: Volume 133(2019)Supplement 1 Page Start: S441 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. PO-1035 Re-Irradiation with high-dose stereotactic radiotherapy for recurrent High-grade Gliomas. (August 2021) Authors: Mousli, A.; Bocquet, V.; Frederick, B.; Louis, C.; Biver, S.; Philippi, S.; Nickers, P.; Untereiner, M.; Vogin, G. Journal: Radiotherapy and oncology Issue: Volume 161(2021)supplement Page Start: S864 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗